Hoe Pharma


Zuellig Pharma
Concise Prescribing Info
Mometasone furoate
Symptomatic treatment of seasonal or perennial rhinitis in adults, adolescents & childn 3-11 yr. Nasal polyps in patients ≥18 yr. Symptomatic treatment of acute rhinosinusitis in patients ≥12 yr w/o signs or symptoms of severe bacterial infection.
Dosage/Direction for Use
Seasonal allergic or perennial rhinitis Adult, elderly & adolescent 2 sprays in each nostril once daily, may be increased to max: 4 sprays in each nostril once daily. Childn 3-11 yr 1 spray in each nostril once daily. Total daily dose: 100 mcg. Nasal polyposis 2 sprays in each nostril bd, may be reduced to 2 sprays in each nostril once daily. Acute rhinosinusitis 2 sprays in each nostril bd.
Special Precautions
Discontinue use if localised fungal nose or pharynx infection & persistent nasopharyngeal irritation develops. Active or quiescent tuberculous resp tract infection or untreated fungal, bacterial, systemic viral infections or ocular herpes simplex; unilateral polyps, polyps associated w/ cystic fibrosis, nasal cavities obstruction; periods of stress or elective surgery. Immunosuppressed patients. W/drawal symptoms during transfer from systemic corticosteroids. High doses & long-term treatment. Not to be used during pregnancy & lactation. Growth retardation in childn. 
Adverse Reactions
Allergic reaction eg, difficulty in breathing, face, lips, tongue or throat swelling. Nosebleed & sores, wheezing, troubled breathing, body aches, flu symptoms. Headache, sore throat, cough, muscle or joint pain.
ATC Classification
R01AD09 - mometasone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.
Elonide nasal spray 50 mcg/dose
((140 doses)) 20 mL x 1's; ((60 doses)) 10 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in